Blocking the SALL4/miR-146a-5p interaction in HCC reduced the expression of inhibitory receptors on T cells, reversed T cell exhaustion, and delayed HCC progression in vivo (Yin C. et al., 2019). This evidence concerns the gene SALL4 and hepatocellular carcinoma.